2-({6-[(4-chlorophenyl)methyl]-5,5-dioxo-5,6-dihydro-5lambda~6~-pyrimido[5,4-c][2,1]benzothiazin-2-yl}sulfanyl)-N-phenylacetamide
Chemical Structure Depiction of
2-({6-[(4-chlorophenyl)methyl]-5,5-dioxo-5,6-dihydro-5lambda~6~-pyrimido[5,4-c][2,1]benzothiazin-2-yl}sulfanyl)-N-phenylacetamide
2-({6-[(4-chlorophenyl)methyl]-5,5-dioxo-5,6-dihydro-5lambda~6~-pyrimido[5,4-c][2,1]benzothiazin-2-yl}sulfanyl)-N-phenylacetamide
Compound characteristics
Compound ID: | G071-0593 |
Compound Name: | 2-({6-[(4-chlorophenyl)methyl]-5,5-dioxo-5,6-dihydro-5lambda~6~-pyrimido[5,4-c][2,1]benzothiazin-2-yl}sulfanyl)-N-phenylacetamide |
Molecular Weight: | 523.03 |
Molecular Formula: | C25 H19 Cl N4 O3 S2 |
Smiles: | C(c1ccc(cc1)[Cl])N1c2ccccc2c2c(cnc(n2)SCC(Nc2ccccc2)=O)S1(=O)=O |
Stereo: | ACHIRAL |
logP: | 4.7969 |
logD: | 4.7969 |
logSw: | -5.0768 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 72.316 |
InChI Key: | OCISSUDVAFMSBS-UHFFFAOYSA-N |